SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Silver Knife who wrote (799)5/17/1999 10:01:00 PM
From: StockMiser  Read Replies (1) of 2344
 
Lori McLeod always uses this same source for Biomira - some French Canadian brokerage no one has heard of, and the answer is always the same..."this was anticipated".

If BLP-25 eliminated all tumors in humans and cured cancer as we know it, Mike Jams would say "BLP-25 appears to function adaquately. It does what it was designed to do, no more, no less. This was anticipated by everyone following the company. We see no fundamental reasons for a change in our valuations at this time."

They make Merrill Lynch look like Don King.

SM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News